Published in Eur Cell Mater on September 24, 2012
Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A (2013) 1.55
Effect of Short-Term Stimulation with Interleukin-1β and Differentiation Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with Osteoblasts. Biomed Res Int (2015) 1.38
Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. Biomaterials (2014) 0.86
Duffy antigen receptor for chemokines regulates post-fracture inflammation. PLoS One (2013) 0.82
Stem Cells for Bone Regeneration: From Cell-Based Therapies to Decellularised Engineered Extracellular Matrices. Stem Cells Int (2016) 0.80
Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways. Cell Death Dis (2016) 0.79
Endochondral ossification for enhancing bone regeneration: converging native extracellular matrix biomaterials and developmental engineering in vivo. Tissue Eng Part B Rev (2014) 0.78
Prolonged performance of a high repetition low force task induces bone adaptation in young adult rats, but loss in mature rats. Exp Gerontol (2015) 0.77
Tissue Engineering Whole Bones Through Endochondral Ossification: Regenerating the Distal Phalanx. Biores Open Access (2015) 0.77
Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation. Sci Rep (2016) 0.76
Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review. Clin Rev Allergy Immunol (2016) 0.76
Fat-Derived Stromal Vascular Fraction Cells Enhance the Bone-Forming Capacity of Devitalized Engineered Hypertrophic Cartilage Matrix. Stem Cells Transl Med (2016) 0.75
A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients. Int J Mol Sci (2017) 0.75
Effects of Dexamethasone Concentration and Timing of Exposure on Chondrogenesis of Equine Bone Marrow-Derived Mesenchymal Stem Cells. Cartilage (2016) 0.75
The role of bioreactors in tissue engineering. Trends Biotechnol (2004) 2.56
Cell differentiation by mechanical stress. FASEB J (2001) 2.56
Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials (2002) 2.22
Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat Nanotechnol (2009) 2.19
Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A (2010) 1.96
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86
Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage (2004) 1.84
Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem (2002) 1.66
Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials (2005) 1.61
Osteochondral tissue engineering. J Biomech (2006) 1.57
Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A (2013) 1.55
Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol (2005) 1.49
Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture. Plast Reconstr Surg (2014) 1.43
A regional system for delivery of primary percutaneous coronary intervention in ST-elevation myocardial infarction: STEMI-St. Cloud. J Invasive Cardiol (2009) 1.40
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther (2007) 1.35
Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells (2005) 1.32
Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum (2002) 1.31
Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells (2007) 1.27
Micro- and nanomechanical analysis of articular cartilage by indentation-type atomic force microscopy: validation with a gel-microfiber composite. Biophys J (2010) 1.26
In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials (2005) 1.26
Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng (2002) 1.26
Visual histological grading system for the evaluation of in vitro-generated neocartilage. Tissue Eng (2006) 1.23
New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol Med (2008) 1.22
Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol (2012) 1.21
Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum (2007) 1.20
Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev (2006) 1.18
Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell (2012) 1.16
Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord (2010) 1.15
Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res (2010) 1.14
Design of graded biomimetic osteochondral composite scaffolds. Biomaterials (2008) 1.12
Lubricin reduces cartilage--cartilage integration. Biorheology (2004) 1.12
Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng (2004) 1.09
Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials (2010) 1.07
Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis Res Ther (2010) 1.07
Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials (2005) 1.07
Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol (2009) 1.05
FGF-2 enhances TGF-beta1-induced periosteal chondrogenesis. J Orthop Res (2004) 1.05
Precultivation of engineered human nasal cartilage enhances the mechanical properties relevant for use in facial reconstructive surgery. Ann Surg (2006) 1.03
Meniscus repair and regeneration: review on current methods and research potential. Eur Cell Mater (2013) 1.02
Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng (2005) 1.01
Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix. Biomaterials (2012) 1.01
Tissue engineering for total meniscal substitution: animal study in sheep model--results at 12 months. Tissue Eng Part A (2012) 1.01
Engineering of large osteogenic grafts with rapid engraftment capacity using mesenchymal and endothelial progenitors from human adipose tissue. Biomaterials (2011) 1.01
The benefit of synthetic versus biological patch augmentation in the repair of posterosuperior massive rotator cuff tears: a 3-year follow-up study. Am J Sports Med (2014) 1.00
Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds. Biotechnol Bioeng (2006) 1.00
The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A (2011) 0.99
Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated bioreactor systems. Tissue Eng (2007) 0.99
Tissue engineering for total meniscal substitution: animal study in sheep model. Tissue Eng Part A (2008) 0.98
The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells (2009) 0.98
The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue Eng Part A (2012) 0.98
TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J Cell Sci (2014) 0.97
MSCs: science and trials. Nat Med (2013) 0.97
A Grid-based solution for management and analysis of microarrays in distributed experiments. BMC Bioinformatics (2007) 0.95
Advanced bioreactor with controlled application of multi-dimensional strain for tissue engineering. J Biomech Eng (2002) 0.95
Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. Stem Cells (2012) 0.95
Expansion on specific substrates regulates the phenotype and differentiation capacity of human articular chondrocytes. J Cell Biochem (2006) 0.94
Surgical treatment of chronic acromioclavicular dislocation: comparison between two surgical procedures for anatomic reconstruction. Injury (2010) 0.94
Three-dimensional cell culture and tissue engineering in a T-CUP (tissue culture under perfusion). Tissue Eng (2007) 0.94
Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis. FEBS Lett (2007) 0.93
Effect of three-dimensional expansion and cell seeding density on the cartilage-forming capacity of human articular chondrocytes in type II collagen sponges. J Biomed Mater Res A (2010) 0.93
Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturing. J Biosci Bioeng (2005) 0.92
Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun (2006) 0.92
Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum (2010) 0.92
In vitro platforms for tissue engineering: implications for basic research and clinical translation. J Tissue Eng Regen Med (2011) 0.92
Solitary psoas muscle metastasis from renal cell carcinoma. ANZ J Surg (2010) 0.91
The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A (2013) 0.91
Do we really need cartilage tissue engineering? Swiss Med Wkly (2009) 0.91
Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts. J Cell Physiol (2010) 0.90
Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® technology. Tissue Eng Part C Methods (2012) 0.90